Liver-function tests in patients receiving iproniazid

descriptionPublicationkeyboard_double_arrow_right Article 01 Dec 1959 English Publisher:Springer Science and Business Media LLCJournal:The American Journal of Digestive Diseases, volume 4, pages 1,027-1,033 (issn: 0002-9211, eissn: 1573-2568,

Copyright policy )

Authors: L, ZETZEL; H, KAPLAN; K T, DUSSIK;

doi: 10.1007/bf02231501

pmid: 13847328

Liver-function tests in patients receiving iproniazid

- Summary
- Subjects
- Metrics

Abstract

Elevations in SGPT may occur in mentally sick patients receiving iproniazid, but they do not foreshadow the inevitable development of liver disease in spite of continued administration of the drug.

Related Organizations

Beth Israel Deaconess Medical Center
United States
Harvard University
United States

Keywords

Liver, Iproniazid

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	5
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average